Vor Biopharma Stock Quote VOR - Stock Price, News, Charts, Message Board, Trades

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Vor Biopharma Inc (VOR) Quote

Vor Biopharma Inc (VOR)

1.08

0.172

( 18.94% )

Updated: 14:32:18

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

1.08

Bid

1.07

Ask

1.08

Volume

2,235,821

0.8277 Day's Range 1.09

0.70 52 Week Range 3.1399

Market Cap

Previous Close

0.908

Open

0.8798

Last Trade

Last Trade Time

14:32:18

Financial Volume

$ 2,146,686

VWAP

0.960133

Average Volume (3m)

733,098

Shares Outstanding

68,398,826

Dividend Yield

-

PE Ratio

-0.61

Earnings Per Share (EPS)

-1.72

Revenue

-

Net Profit

-117.86M

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.vorbio.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker VOR. The last closing price for Vor Biopharma was $0.91. Over the last year, Vor Biopharma shares have traded in a share price range of $ 0.70 to $ 3.1399.

Vor Biopharma currently has 68,398,826 shares outstanding. The market capitalization of Vor Biopharma is $62.11 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.61.

FeaturedElement79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd.

Form 8-K - Current report

New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies

Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefitVCAR33ALLO demonstrates encouraging biomarker data at lowest dose New asset VADC45 with...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following...

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update

On-track for trem-cel + Mylotarg™ and VCAR33ALLO clinical updates in the second half of 2024 CAMBRIDGE, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.191	21.4848143982	0.889	1.16	0.82	6922540	0.88894225	CS
4	0.25	30.1204819277	0.83	1.16	0.8193	1662050	0.89395667	CS
12	-0.07	-6.08695652174	1.15	1.27	0.7	733098	0.91926952	CS
26	-1.23	-53.2467532468	2.31	2.43	0.7	498773	1.20761424	CS
52	-1.43	-56.9721115538	2.51	3.1399	0.7	339449	1.46248767	CS
156	-15.11	-93.3292155652	16.19	18.515	0.7	201797	3.74438925	CS
260	-40.94	-97.4297953356	42.02	63.62	0.7	199750	7.98597176	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SINTSiNtx Technologies Inc	$ 5.0299 (78.37%)	63.94M
SMMTSummit Therapeutics Inc	$ 19.52 (59.09%)	41.16M
NBSTWNewbury Street Acquisition Corporation	$ 0.08 (59.05%)	9.4k
RLAYRelay Therapeutics Inc	$ 9.40 (50.64%)	15.16M
INBSIntelligent Bio Solutions Inc	$ 2.345 (48.42%)	83.57M
EGIOEdgio Inc	$ 1.2112 (-80.37%)	4.08M
PEGYPineapple Energy Inc	$ 0.2939 (-63.69%)	9.55M
TCBPTC BioPharm Holdings PLC	$ 5.11 (-34.90%)	341.48k
CACOCaravelle International Group	$ 0.28 (-26.53%)	466.27k
WHLRWheeler Real Estate Investment Trust Inc	$ 7.65 (-25.37%)	7.78M
WTOUTime Limited	$ 0.05015 (-24.02%)	216.46M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.1701 (19.37%)	216.19M
NVDANVIDIA Corporation	$ 105.22 (2.32%)	197.61M
SQQQProShares UltraPro Short QQQ	$ 9.49 (-2.37%)	133.69M
INBSIntelligent Bio Solutions Inc	$ 2.35 (48.73%)	83.57M

PonkenPlonken

PonkenPlonken 4 days ago

remember this was founded to heal patients, not retire the management. This is a mission by the brilliant founder and the $$ will come as a by product of things being very right.

PonkenPlonken

PonkenPlonken 4 days ago

Helps where CAR T cant in AML. Its about giving MORE of the drugs that heal..... they work but the body cant handle them. With VOR, it can.

People might just start realizing how huge the possibilities for this are.... GIVEN: r/r AML makes up 40-50% in younger patients and the great majority of elderly patients.
Now experiment with the 20bn TAM for r/r AML and some funny numbers start popping up.
Look at the founder... hes onto something.

the actual data will speak soon. The investigator is ultra optimistic.... he likely saw more.

glenn1919

glenn1919 4 days ago

VOR................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 2 months ago

VOR new 52 week low

Monksdream

Monksdream 2 months ago

VOR new 52 week low

PonkenPlonken

PonkenPlonken 2 months ago

Sid Mukherjee saw the potential in Saar Gills and Carl Junes approach and funded VOR==== shielding the right cells and attacking the cancer. For simplicity, it could be summed up as bottom up selectivity.................
Very different from all the other CAR T stuff out there that is pretty much top-down-y. And in my opinion, top down systems dont work.
5am and RA certainly think so. Will go back to the IPO price and then some is my bet.

Monksdream

Monksdream 2 months ago

GNPX new 52 week low

PonkenPlonken

PonkenPlonken 2 months ago

Im starting to think someone just buys them out.
Interesting action yesterday.

Monksdream

Monksdream 3 months ago

VOR new 52 week low

Monksdream

Monksdream 3 months ago

VOR new 52 week low

PonkenPlonken

PonkenPlonken 4 months ago

elevated volume for quite some time now.

PonkenPlonken

PonkenPlonken 5 months ago

https://en.wikipedia.org/wiki/Siddhartha_Mukherjee founder is a smart man. They can do Car T without the tox.

Monksdream

Monksdream 6 months ago

glenn1919

glenn1919 6 months ago

VOR.....................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783

Delayed Upgrade Clock